1-ethyl-6-fluoro-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]piperazin-1-yl]-4-oxoquinoline-3-carboxylic acid

Name: Serum level of compound (50 mg/kg) after 0.25 hr of peroral administration in mice
Source: ChEMBL
Target: Mus musculus
External Id: CHEMBL875982

Name: Serum level of compound (50 mg/kg) after 0.50 hr of peroral administration in mice
Source: ChEMBL
Target: Mus musculus
External Id: CHEMBL630895

Name: Serum level of compound (50 mg/kg) after 1.0 hr of peroral administration in mice
Source: ChEMBL
Target: Mus musculus
External Id: CHEMBL630896

Name: Serum level of compound (50 mg/kg) after 2.0 hr of peroral administration in mice
Source: ChEMBL
Target: Mus musculus
External Id: CHEMBL630897

Name: Minimum inhibitory concentration tested against Bacillus subtilis ATCC 6633
Source: ChEMBL
Target: Bacillus subtilis
External Id: CHEMBL857911

Name: Serum level of compound (50 mg/kg) after 3.0 hh of peroral administration in mice
Source: ChEMBL
Target: Mus musculus
External Id: CHEMBL630898

Name: Area under curve value of compound per hour after oral administration
Source: ChEMBL
Target: N/A
External Id: CHEMBL624135

Name: Serum level of compound (50 mg/kg) after 4.0h of peroral administration in mice
Source: ChEMBL
Target: Mus musculus
External Id: CHEMBL630899

Name: Effective dose of compound against Escherichia coli KC-14 in rats after oral administ...
Source: ChEMBL
Target: Escherichia coli
External Id: CHEMBL674153

Name: Oral efficacy of compound after peroral administration on systemic infection by Esche...
Source: ChEMBL
Target: Escherichia coli
External Id: CHEMBL674154